Amfepramone
| Systematic (IUPAC) name | |
|---|---|
| (RS)-2-diethylamino-1-phenylpropan-1-one | |
| Clinical data | |
| Trade names | Tenuate |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a682037 |
| Pregnancy cat. | B |
| Legal status | Schedule IV (US) |
| Routes | Oral |
| Identifiers | |
| CAS number | 134-80-5 |
| ATC code | A08AA03 |
| PubChem | CID 7029 |
| DrugBank | DB00937 |
| ChemSpider | 6762 |
| UNII | 19V2PL39NG |
| KEGG | D07444 |
| ChEBI | CHEBI:4530 |
| ChEMBL | CHEMBL1194666 |
| Synonyms | Diethylpropion |
| Chemical data | |
| Formula | C13H19NO |
| Mol. mass | 205.30 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
Amfepramone (INN, other names diethylcathinone and diethylpropion, trade names Anorex, Linea, Nobesine, Prefamone, Regenon, Tepanil, Tenuate), is a stimulant drug of the phenethylamine, amphetamine, and cathinone chemical classes that is used as an appetite suppressant.
Contents |
[edit] Pharmacology
Amfepramone itself lacks any affinity for the monoamine transporters and instead functions as a prodrug to ethcathinone.[1] Ethcathinone (and therefore amfepramone as well) is a very weak dopaminergic and serotonergic, and is approximately 10x and 20x stronger on norepinephrine in comparison, respectively.[1] As a result, ethcathinone and amfepramone can essentially be considered selective norepinephrine releasing agents (NRAs).
[edit] Abuse
Amfepramone is believed to have relatively low abuse potential.[2][3][4][5]
[edit] Legality
Amfepramone is classified as a Schedule IV controlled substance in the United States. In the UK Amfepramone is a class C drug.[6]
[edit] Chemistry
- Propiophenone is brominated to produce α-bromopropiophenone.
- This is reacted with diethylamine to yield the product, diethylpropion.
Reference: U.S. Patent 3,001,910 Hyde, J. F.; Browning, E.; Adams, R. (1928). Journal of the American Chemical Society 50 (8): 2287. doi:10.1021/ja01395a032.
[edit] See also
[edit] References
- ^ a b Rothman RB, Baumann MH (2006). "Therapeutic potential of monoamine transporter substrates". Current Topics in Medicinal Chemistry 6 (17): 1845–59. doi:10.2174/156802606778249766. PMID 17017961. http://www.bentham-direct.org/pages/content.php?CTMC/2006/00000006/00000017/0004R.SGM.
- ^ Cohen S (1977). "Diethylpropion (tenuate): an infrequently abused anorectic". Psychosomatics 18 (1): 28–33. PMID 850721. http://psy.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=850721.
- ^ Jasinski DR, Krishnan S (June 2009). "Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse". Journal of Psychopharmacology 23 (4): 419–27. doi:10.1177/0269881109103113. PMID 19329547.
- ^ http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=1611
- ^ CAPLAN J (May 1963). "Habituation to diethylpropion (Tenuate)". Canadian Medical Association Journal 88: 943–4. PMC 1921278. PMID 14018413. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1921278.
- ^ http://www.statutelaw.gov.uk/content.aspx?LegType=All+Legislation&title=The+Misuse+of+Drugs+Act+1971&searchEnacted=0&extentMatchOnly=0&confersPower=0&blanketAmendment=0&sortAlpha=0&TYPE=QS&PageNumber=1&NavFrom=0&parentActiveTextDocId=1367412&ActiveTextDocId=1367471&filesize=1699
|
|
|
|
|

